Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis Keiichiro MoriHadi MostafaeiShahrokh F. Shariat Review Open access 05 August 2020 Pages: 265 - 273
Identification of STXBP6-IRF1 positive feedback loop in regulation of PD-L1 in cancer Yanbin LiuZhicong HuangHaihe Wang Original Article 22 July 2020 Pages: 275 - 287
Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer Aung Kyi Thar MinKosaku MimuraKoji Kono Original Article 23 July 2020 Pages: 289 - 298
Improved survival in patients with thyroid function test abnormalities secondary to immune-checkpoint inhibitors Joana Lima FerreiraCláudia CostaIsabel Torres Original Article 25 July 2020 Pages: 299 - 309
B7-H3 is spliced by SRSF3 in colorectal cancer Chunxia ZhangYinshuang ChenWeipeng Wang Original Article 27 July 2020 Pages: 311 - 321
Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L1 Anna MakowskaSelina MeierUdo Kontny Original Article Open access 31 July 2020 Pages: 323 - 336
A high number of PD-L1+ CD14+ monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors Kiyohiro AndoKazuyuki HamadaSatoshi Wada Original Article 05 August 2020 Pages: 337 - 348
Expression pattern, regulation, and clinical significance of TOX in breast cancer Mohit AroraSarita KumariShyam S. Chauhan Original Article 05 August 2020 Pages: 349 - 363
Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity Yan WangHaiqing NiJunjian Liu Original Article 06 August 2020 Pages: 365 - 376
Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma Zhi-Qiang HuHao-Yang XinShao-Lai Zhou Original Article 06 August 2020 Pages: 377 - 389
Evaluation of antitumor immunity by a combination treatment of high-dose irradiation, anti-PDL1, and anti-angiogenic therapy in murine lung tumors Jenny Ling-Yu ChenChun-Kai PanMing-Jium Shieh Original Article 06 August 2020 Pages: 391 - 404
Chemotherapy negatively impacts the tumor immune microenvironment in NSCLC: an analysis of pre- and post-treatment biopsies in the multi-center SAKK19/09 study M. A. AmreinE. D. BührerA. F. Ochsenbein Original Article Open access 07 August 2020 Pages: 405 - 415
Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma Li-Li LiuShi-Wen ZhangRong-Zhen Luo Original Article Open access 07 August 2020 Pages: 417 - 429
Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy Sumi YunJiwon KohHye Seung Lee Original Article 12 August 2020 Pages: 431 - 441
The impact of ICOS+ regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapy Shinya UrakawaMakoto YamasakiHisashi Wada Original Article 16 August 2020 Pages: 443 - 452
PD-L1+ lung cancer stem cells modify the metastatic lymph-node immunomicroenvironment in nsclc patients A. RaniszewskaH. VromanJ. Domagała-Kulawik Original Article Open access 17 August 2020 Pages: 453 - 461
Tumor cell-derived autophagosomes (DRibbles)-activated B cells induce specific naïve CD8+ T cell response and exhibit antitumor effect Tian-Yu ZhangHong-Yan RenLi-Xin Wang Original Article 18 August 2020 Pages: 463 - 474
Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection Georgia M. BeasleyAaron D. TherienSmita K. Nair Original Article 19 August 2020 Pages: 475 - 483
Immunogenic necroptosis in the anti-tumor photodynamic action of BAM-SiPc, a silicon(IV) phthalocyanine-based photosensitizer Ying ZhangYing-Kit CheungWing-Ping Fong Original Article 24 August 2020 Pages: 485 - 495
The introduction of immunosuppressor (TDO inhibitor) significantly improved the efficacy of irinotecan in treating hepatocellular carcinoma Qingqing LiuShixian HuaShaohua Gou Original Article 25 August 2020 Pages: 497 - 508
T-cell complexity and density are associated with sensitivity to neoadjuvant chemoradiotherapy in patients with rectal cancer Takashi AkiyoshiOsamu GotohSeiichi Mori Original Article 26 August 2020 Pages: 509 - 518
Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer Alexandra LearyCatherine GenestieAya S. Khairallah Original Article Open access 27 August 2020 Pages: 519 - 531
Development of nomograms to predict therapeutic response and prognosis of non-small cell lung cancer patients treated with anti-PD-1 antibody Shijin YuanYan XiaJun Zhang Original Article 27 August 2020 Pages: 533 - 546
Curdlan, zymosan and a yeast-derived β-glucan reshape tumor-associated macrophages into producers of inflammatory chemo-attractants Priscilla de GraaffCor BerrevoetsCoen Govers Original Article Open access 29 August 2020 Pages: 547 - 561
Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients Omar Hasan AliFiamma BernerLukas Flatz Research Report Open access 17 August 2020 Pages: 563 - 568
